Verrica Pharmaceuticals Inc.
VRCA
$6.11
-$0.04-0.65%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 30.15M | 21.10M | 15.40M | 29.60M | 46.33M |
| Total Receivables | 5.40M | 7.33M | 17.37M | 5.65M | 77.00K |
| Inventory | 2.24M | 2.30M | 2.52M | 2.46M | 2.46M |
| Prepaid Expenses | 2.80M | 3.59M | 1.49M | 1.77M | 2.31M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.96M | 1.96M | -- | -- | -- |
| Total Current Assets | 42.54M | 36.28M | 36.78M | 39.47M | 51.18M |
|
|
|||||
| Total Current Assets | 42.54M | 36.28M | 36.78M | 39.47M | 51.18M |
| Net Property, Plant & Equipment | 1.86M | 1.89M | 1.95M | 2.33M | 2.58M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.73M | 2.73M | 376.00K | 376.00K | 376.00K |
| Total Assets | 47.13M | 40.90M | 39.11M | 42.18M | 54.13M |
|
|
|||||
| Total Accounts Payable | 2.07M | 1.59M | 2.32M | 1.44M | 1.90M |
| Total Accrued Expenses | 4.03M | 3.88M | 3.13M | 3.29M | 3.09M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 746.00K | 13.16M | 13.32M | 13.47M | 13.61M |
| Total Finance Division Other Current Liabilities | 9.59M | 10.28M | 10.46M | 11.20M | 10.42M |
| Total Other Current Liabilities | 9.59M | 10.28M | 10.46M | 11.20M | 10.42M |
| Total Current Liabilities | 16.44M | 28.91M | 29.22M | 29.40M | 29.01M |
|
|
|||||
| Total Current Liabilities | 16.44M | 28.91M | 29.22M | 29.40M | 29.01M |
| Long-Term Debt | -- | 21.62M | 24.58M | 27.81M | 30.98M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 885.00K | 959.00K | 995.00K | 1.16M | 1.35M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.07M | 6.45M | 1.80M | 2.39M | 2.65M |
| Total Liabilities | 22.39M | 57.94M | 56.59M | 60.75M | 63.99M |
|
|
|||||
| Common Stock & APIC | 349.66M | 299.80M | 299.08M | 298.19M | 297.17M |
| Retained Earnings | -324.91M | -316.84M | -316.57M | -316.77M | -307.03M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 24.74M | -17.04M | -17.48M | -18.58M | -9.86M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 24.74M | -17.04M | -17.48M | -18.58M | -9.86M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 24.74M | -17.04M | -17.48M | -18.58M | -9.86M |
|
|
|||||